HPV31 sublineages | Variants | Normal (n = 46) | CIN1 (n = 8) | CIN2 (n = 14) | CIN3 (n = 12) | Cancer (n = 0) | Total (n = 80) |
---|---|---|---|---|---|---|---|
A2 | 24(52.2%) | 4(50.0%) | 10(71.4%) | 8(66.7%) | 0 | 46(57.5%) | |
31CNTZ01 | 2(4.3%) | 0 | 0 | 0 | 0 | 2(2.5%) | |
31CNTZ02 | 1(2.2%) | 2(25.0%) | 0 | 0 | 0 | 3(3.8%) | |
31CNTZ04 | 9(19.6%) | 0 | 2(14.2%) | 2(16.7%) | 0 | 13(16.3%) | |
31CNTZ05 | 1(2.2%) | 0 | 0 | 0 | 0 | 1(1.3%) | |
31CNTZ06 | 0 | 1(12.5%) | 0 | 0 | 0 | 1(1.3%) | |
31CNTZ07 | 11(23.9%) | 1(12.5%) | 7(50%) | 6(50.0%) | 0 | 25(31.3%) | |
31CNTZ10 | 0 | 0 | 1(7.1%) | 0 | 0 | 1(1.3%) | |
B1 | 1(2.2%) | 1(12.5%) | 0 | 0 | 0 | 2(2.5%) | |
31CNTZ12 | 1(2.2%) | 1(12.5%) | 0 | 0 | 0 | 2(2.5%) | |
C2 | 14(30.4%) | 3(37.5%) | 4(28.6%) | 3(25%) | 0 | 24(30%) | |
31CNTZ15 | 14(30.4%) | 3(37.5%) | 4(28.6%) | 2(16.7%) | 0 | 23(28.8%) | |
31CNTZ16 | 0 | 0 | 0 | 1(8.3%) | 0 | 1(1.3%) | |
C3 | 7(15.2%) | 0 | 0 | 1(8.3%) | 0 | 8(10.0%) | |
31CNTZ13 | 6(13.0%) | 0 | 0 | 1(8.3%) | 0 | 7(8.8%) | |
31CNTZ14 | 1(2.2%) | 0 | 0 | 0 | 0 | 1(1.3%) |